OpGen, Inc. (OPGN)

OTCMKTS · Delayed Price · Currency is USD
24.00
-0.50 (-2.04%)
Mar 2, 2026, 3:50 PM EST
Market Cap292.28M +2,020.0%
Revenue (ttm)9.00M +611.0%
Net Income6.71M
EPS0.38
Shares Out12.18M
PE Ratio63.82
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,807
Average Volume6,155
Open20.00
Previous Close24.50
Day's Range20.00 - 24.00
52-Week Range0.00 - 34.00
Beta-3,325.90
RSI43.28
Earnings DateMar 24, 2026

About OpGen

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGe... [Read more]

Sector Healthcare
Founded 2001
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol OPGN
Full Company Profile

Financial Performance

Financial Statements